4.5 Review

Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Metastatic Voyage of Ovarian Cancer Cells in Ascites with the Assistance of Various Cellular Components

Kaname Uno et al.

Summary: This review highlights the significance of accumulating ascites, EOC cells in the form of spheroids, and interaction with non-malignant host cells in epithelial ovarian cancer (EOC). The formation of spheroids allows EOC cells to become resistant against anoikis and gain the ability to invade and metastasize. Additionally, hetero-cellular spheroids composed of non-malignant cells are shown to have a higher adhesion ability. Understanding the mechanisms of spheroid formation and interactions with non-malignant cells in ascites is crucial for improving the prognosis of EOC.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Oncology

Epigenetic Regulation: A Link between Inflammation and Carcinogenesis

Bianca Vezzani et al.

Summary: Epigenetics refers to a group of dynamic, reversible, and heritable modifications within cells that are not caused by gene mutations. These modifications are highly influenced by the surrounding environment and the internal microenvironments of tissues and cells. Understanding the interaction between the tumor microenvironment and cancer cells in terms of epigenetic networks may reveal new targetable mechanisms to prevent tumor progression.

CANCERS (2022)

Article Oncology

Disulfiram Transcends ALDH Inhibitory Activity When Targeting Ovarian Cancer Tumor-Initiating Cells

Michael W. Caminear et al.

Summary: The study found that disulfiram was more effective in reducing the viability of TICs compared to NCTs, affecting NF kappa B signaling, and was more suitable as a therapeutic to prevent EOC relapse.

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

Effect of Apatinib Plus Pegylated Liposomal Doxorubicin vs Pegylated Liposomal Doxorubicin Alone on Platinum-Resistant Recurrent Ovarian Cancer The APPROVE Randomized Clinical Trial

Tiantian Wang et al.

Summary: This study evaluated the efficacy and safety of apatinib plus PLD in treating patients with PROC. The results showed promising efficacy and manageable toxic effects in PROC patients treated with apatinib plus PLD.

JAMA ONCOLOGY (2022)

Review Pathology

The Origin of Ovarian Cancer Species and Precancerous Landscape

Ie-Ming Shih et al.

Summary: Ovarian epithelial cancers are mainly imported from endometrial or fallopian tube epithelium, unlike other human cancers that arise de novo. High-grade serous carcinoma develops in fallopian tubes through stepwise tumor progression, with recent advances allowing for early diagnosis and treatment of HGSC.

AMERICAN JOURNAL OF PATHOLOGY (2021)

Article Oncology

Characterization of SOX2, OCT4 and NANOG in Ovarian Cancer Tumor-Initiating Cells

Mikella Robinson et al.

Summary: The findings suggest that SOX2 may be a more consistent indicator of ovarian tumor initiating cells (TICs) that contribute to tumor repopulation following chemotherapy. Further studies evaluating SOX2 in TIC biology will enhance understanding of mechanisms driving ovarian cancer relapse.

CANCERS (2021)

Article Oncology

Morphological and molecular characteristics of spheroid formation in HT-29 and Caco-2 colorectal cancer cell lines

Elmira Gheytanchi et al.

Summary: The study aimed to assess the capability of HT-29 and Caco-2 cell lines in generating spheroids with CSC-related features and detailed morphological and molecular characteristics. Both cell lines formed CSCs-enriched spheroids, identified by their ability to serial sphere formation, up-regulation of stemness genes, and increased expression of CRC-CSC markers. The spheroid culture model without special scaffold/biochemical proved to be a robust, reproducible, simple, and cost-effective method for in vitro research of CRC-CSCs, including self-renewal, drug resistance, and invasion.

CANCER CELL INTERNATIONAL (2021)

Review Cell Biology

Cellular models of development of ovarian high-grade serous carcinoma: A review of cell of origin and mechanisms of carcinogenesis

Jie Mei et al.

Summary: HGSC is the most common and malignant histological type of epithelial ovarian cancer, with controversial origin believed to be the secretory epithelial cells of the fallopian tube. Research focus has shifted towards understanding the cell origin, immortalization process, and malignant transformation mechanisms.

CELL PROLIFERATION (2021)

Review Biochemistry & Molecular Biology

The Cancer Stem Cell Niche in Ovarian Cancer and Its Impact on Immune Surveillance

Srishti Jain et al.

Summary: This review summarizes the current evidence-based knowledge on the cancer stem cell niche within the ovarian cancer tumor microenvironment and its effect on immune surveillance, along with highlighting current therapies targeting these processes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Medicine, General & Internal

Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Usha Menon et al.

Summary: The long-term follow-up of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) did not show a significant reduction in deaths due to ovarian or tubal cancer with screening. While there was an increase in early-stage cancer detection in the MMS group, it did not translate into lives saved, highlighting the importance of specifying cancer mortality as the primary outcome in screening trials. Consequently, general population screening for ovarian and tubal cancer cannot be recommended.

LANCET (2021)

Article Multidisciplinary Sciences

Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing

Abhijeet P. Deshmukh et al.

Summary: This study identified the complexity of the EMT process by analyzing gene expression profiles during EMT progression. It demonstrated that NOTCH signaling pathway drives TGF-beta-induced EMT, and gene signatures corresponding to intermediate hybrid EMT state are associated with poor patient outcome.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Review Oncology

Ovarian Cancer-Associated Mesothelial Cells: Transdifferentiation to Minions of Cancer and Orchestrate Developing Peritoneal Dissemination

Kazumasa Mogi et al.

Summary: Ovarian cancer-associated mesothelial cells play a crucial role in the progression of ovarian cancer by aiding in invasion and dissemination, contributing to the poor prognosis of the disease.

CANCERS (2021)

Article Multidisciplinary Sciences

The many faces of cancer evolution

Giovanni Ciriello et al.

Summary: Cancer cells undergo genotypic and phenotypic changes during the disease progression, with some changes enhancing cell fitness and enabling tumor evolution and resistance to treatment. Cancer evolution is driven by different processes, including genetic variants and plastic reprogramming. Understanding and utilizing cell plasticity in tumor evolution is essential for addressing the challenges presented by cancer.

ISCIENCE (2021)

Article Oncology

Statin use and survival among women with ovarian cancer: an Australian national data-linkage study

Jia-Li Feng et al.

Summary: The use of statins may provide a survival benefit for women with ovarian cancer, particularly for those with endometrioid cancers. However, bias in observational studies poses challenges in conclusively establishing this association.

BRITISH JOURNAL OF CANCER (2021)

Review Biochemistry & Molecular Biology

Cancer evolution: Darwin and beyond

Roberto Vendramin et al.

Summary: Cancer evolution is not solely explained by the Darwinian model, but also involves factors such as macroevolutionary events, neutral evolution, and even the aging of somatic cells. These elements collectively form a model of cancer evolution that extends beyond Darwin.

EMBO JOURNAL (2021)

Article Multidisciplinary Sciences

Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer

Aritro Nath et al.

Summary: The study reveals the core archetypes in progressive HGSOC and demonstrates consistent enrichment of subclones with the metabolism and proliferation archetype as resistance is acquired to multiple lines of therapy. The shifts in metabolism and proliferation are associated with treatment response and clonal heterogeneity in HGSOC.

NATURE COMMUNICATIONS (2021)

Review Immunology

Shaping Immune Responses in the Tumor Microenvironment of Ovarian Cancer

Xin Luo et al.

Summary: Reciprocal signaling between immune cells and ovarian cancer cells in the tumor microenvironment is regulated by various factors and plays a crucial role in disease progression. Recent studies have revealed the complexity of interactions between different immune cell types in the ovarian cancer tumor microenvironment, providing insights for biomarker discovery and therapeutic development.

FRONTIERS IN IMMUNOLOGY (2021)

Review Medicine, General & Internal

Comparison of the Genomic Profile of Cancer Stem Cells and Their Non-Stem Counterpart: The Case of Ovarian Cancer

Elena Laura Mazzoldi et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Review Oncology

Epigenetic Attire in Ovarian Cancer: The Emperor's New Clothes

Daniela Matei et al.

CANCER RESEARCH (2020)

Review Oncology

Novel Therapeutic Strategies for Ovarian Cancer Stem Cells

Nastassja Terraneo et al.

FRONTIERS IN ONCOLOGY (2020)

Review Cell Biology

Tumor Microenvironment in Ovarian Cancer: Function and Therapeutic Strategy

Yanfei Yang et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Review Oncology

Evolving insights: how DNA repair pathways impact cancer evolution

Jiadong Zhou et al.

CANCER BIOLOGY & MEDICINE (2020)

Review Genetics & Heredity

The emerging links between chromosomal instability (CIN), metastasis, inflammation and tumour immunity

Andrea E. Tijhuis et al.

MOLECULAR CYTOGENETICS (2019)

Review Oncology

Chromosomal Instability in Tumor Initiation and Development

Duc-Hiep Bach et al.

CANCER RESEARCH (2019)

Article Multidisciplinary Sciences

Acquisition of a side population fraction augments malignant phenotype in ovarian cancer

Koji Yamanoi et al.

SCIENTIFIC REPORTS (2019)

Review Cell Biology

Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review

Juliette O. A. M. van Baal et al.

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2018)

Article Reproductive Biology

Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors

Alicia Beeghly-Fadiel et al.

JOURNAL OF OVARIAN RESEARCH (2018)

Article Genetics & Heredity

Copy number signatures and mutational processes in ovarian carcinoma

Geoff Macintyre et al.

NATURE GENETICS (2018)

Review Biochemistry & Molecular Biology

The peritoneal soil for a cancerous seed: a comprehensive review of the pathogenesis of intraperitoneal cancer metastases

Justyna Mikula-Pietrasik et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2018)

Article Multidisciplinary Sciences

High grade serous ovarian carcinomas originate in the fallopian tube

S. Intidhar Labidi-Galy et al.

NATURE COMMUNICATIONS (2017)

Article Multidisciplinary Sciences

Chromosome instability drives phenotypic switching to metastasis

ChongFeng Gao et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Cell Biology

Epigenetic Determinants of Cancer

Stephen B. Baylin et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)

Article Multidisciplinary Sciences

Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution

Thomas E. Bartlett et al.

NATURE COMMUNICATIONS (2016)

Article Medicine, General & Internal

Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis

Roland F. Schwarz et al.

PLOS MEDICINE (2015)

Article Biochemistry & Molecular Biology

Genomic and transcriptomic plasticity in treatment-naive ovarian cancer

Marlous Hoogstraat et al.

GENOME RESEARCH (2014)

Article Oncology

Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer

Gottfried E. Konecny et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)

Article Pathology

Fallopian Tube Intraluminal Tumor Spread From Noninvasive Precursor Lesions

Jonathan G. Bijron et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)

Review Biochemistry & Molecular Biology

The epigenetics of epithelial-mesenchymal plasticity in cancer

Wai Leong Tam et al.

NATURE MEDICINE (2013)

Review Multidisciplinary Sciences

Epigenetic Reprogramming in Cancer

Mario L. Suva et al.

SCIENCE (2013)

Article Multidisciplinary Sciences

Integrated genomic analyses of ovarian carcinoma

D. Bell et al.

NATURE (2011)

Article Pathology

The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory

Robert J. Kurman et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)

Article Cell Biology

Proliferation of aneuploid human cells is limited by a p53-dependent mechanism

Sarah L. Thompson et al.

JOURNAL OF CELL BIOLOGY (2010)

Review Oncology

Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management

Masaki Mandai et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2009)

Article Biochemistry & Molecular Biology

Epigenetic regulation of CD133 and tumorigenicity of CD133+ovarian cancer cells

T. Baba et al.

ONCOGENE (2009)

Article Pathology

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship

David W. Kindelberger et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)

Article Multidisciplinary Sciences

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness

Paul P. Szotek et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Medicine, Research & Experimental

Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma

A Horiuchi et al.

LABORATORY INVESTIGATION (2003)